Comparison of Naturalistic Treatment Outcomes with the Standard 38-Minute Protocol vs. Shortened (“Dash”) Protocol: A NeuroStar® Registry Database Study

• W. Scott West, MD,
• Linda L. Carpenter, MD,
• Scott T. Aaronson, MD,
• Sarah Verdoliva Boatman, MS,
• Todd M. Hutton, MD,
• Miriam Mina, BS,
• Kenneth Pages, MD,
• Harold A. Sackeim, PhD

Affiliations

W. Scott West, MD

Medical Director, Nashville NeuroCare Therapy; Consultant, Neuronetics Inc

Linda L. Carpenter, MD

Department of Psychiatry and Human Behavior, Warren Alpert Medical School at Brown University; Chief, Mood Disorders Program, Butler Hospital; Attending Psychiatrist, Butler Hospital; Attending Psychiatrist, Kent County Memorial Hospital; Director, Butler Hospital TMS Clinic; Director, Butler Neuromodulation Research Facility; Scientific advisor to Neuronetics Inc, Nexstim PLC, Affect Neuro Inc, Neurolief LTD, and Janssen Pharmaceuticals Inc

Scott T. Aaronson, MD

Director of Clinical Research Programs, Sheppard Pratt Health System; Psychiatrist and Psychopharmacologist to The Retreat at Sheppard Pratt; Director, Transcranial Magnetic Stimulation Services, Sheppard Pratt; Adjunct Associate Professor, Psychiatry, University of Maryland School of Medicine; Scientific adviser to Neuronetics Inc, Genomind Inc, LivaNova PLC, Janssen Pharmaceuticals Inc, and has received research support from Compass Pathways Inc and Neuronetics Inc

Sarah Verdoliva Boatman, MS

Principal Biostatistician, NAMSA

Todd M. Hutton, MD

Founder and Medical Director, Southern California TMS Center; Consultant, Neuronetics Inc

Miriam Mina, BS

Associate Director of Clinical Applications, Neuronetics Inc

Kenneth Pages, MD

Medical Director, TMS of South Tampa; Voluntary Faculty, Department of Psychiatry, University of South Florida; Consultant, Neuronetics Inc

Harold A. Sackeim, PhD

Departments of Psychiatry and Radiology, College of Physicians and Surgeons, Columbia University; Emeritus Chief, Department of Biological Psychiatry, New York State Psychiatric Institute; Founding Editor, Brain Stimulation: Basic, Translational and Clinical Research in Neuromodulation; Scientific adviser to Neuronetics Inc., LivaNova PLC, and MECTA Corporation